17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

Clinical trial NCT00132015 · COMPLETED

Trial details

NCT number: NCT00132015
Sponsor: National Institutes of Health Clinical Center (CC)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Lymphoma Nonneoplastic Condition Precancerous Condition

Start date: 2006-05-01
Primary completion: 2007-12-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.